Pfizer Halts Obesity Pill Development Amid Safety Concerns

• click to rate

  Posted by Two Blokes Apr 15 - Filed in Stock - 2 views
  
  PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.